Izokibep is an investigational small protein therapeutic designed to selectively inhibit interleukin-17A (IL-17A), a pro-inflammatory cytokine implicated in various autoimmune and inflammatory diseases.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.